PlainPharmaWatch

CMS Open Payments · Program Year 2024

DeGen Medical, Inc.

DeGen Medical, Inc. reported $324,899.84 across General Payments, Research, and Ownership to 204 physicians and teaching hospitals across 204 transactions.

See the rankings → How this is sourced
$324.9K Above-median payer
All-tracks total
204 Above-median volume
Transactions
204 Above-median reach
Recipients
+$11.6K
General Payments vs PY2023

DeGen Medical, Inc. reported $324,899.84 across all CMS Open Payments tracks (General + Research + Ownership) to 204 physicians and teaching hospitals in Program Year 2024 - ranking #877 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $324,899.84, averaging $1.6K per recipient.

DeGen Medical, Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

25/100

Total payments

F

13/100

Transaction volume

F

11/100

Physician reach

F

12/100

Payment type diversity

D

63/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer degen-medical-inc DeGen Medical, Inc.

$324.9K · #877/1,925 · 0.0% industry · PY2024

  • TOT $324.9K
  • RANK #877
  • SHARE 0.0%
  • TXN 204
  • RCP 204
  • CAT 5
  • GEN $324.9K
  • ΔGEN +$11.6K
  • TOP1 37.0%
  • PY 2024

Volume peers

Nearest volume peer: Endogastric Solutions, Inc ($325.4K)

Brainsway USA INC$326.1KBioCryst Pharmaceuticals, In…$326.1KEndogastric Solutions, Inc$325.4KDeGen Medical, Inc. (this)$324.9KMedAlliance LLC$323.3K
All-tracks payment totals near DeGen Medical, Inc. (CMS Open Payments PY2024)

DeGen Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

DeGen Medical, Inc.'s CMS-reported General Payments increased by $11.6K (+3.7%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: DEGEN MEDICAL, INC.PY2023: DEGEN MEDICAL, INC.PY2024: DeGen Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$313.3KPY2024$324.9K
PY2023
$313,293.92
PY2024
$324,899.84

What the Data Shows for DeGen Medical, Inc.

CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For DeGen Medical, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.

Of the 5 general-payment categories charted below, "Royalty or License" is the largest at $268.1K across 105 transactions, 82.5% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Royalty or License" leads DeGen Medical, Inc.'s 5-category general-payment breakdown at $268.1K, 82.5% of the reported total.

DeGen Medical, Inc. reports 5 general-payment categories - the top three are Royalty or License (82.5%), Consulting Fee (6.4%), and Travel and Lodging (6.0%). The remaining 2 categories make up 5.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How DeGen Medical, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Royalty or License$268.1K2. Consulting Fee$20.9K3. Travel and Lodging$19.4K4. Grant$10.0K5. Food and Beverage$6.5K
Payment Type Amount Transactions
Royalty or License $268.1K 105
Consulting Fee $20.9K 32
Travel and Lodging $19.4K 14
Grant $10.0K 2
Food and Beverage $6.5K 51

Recipient Concentration in General Payments

The five largest recipient relationships account for $262,830.43 (80.9%) of $324,899.84 in this company's General Payments records across 47 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for DeGen Medical, Inc.

The five named recipients with the highest reported General Payments from this company

Rakesh Chokshi$120.1KWillie EDWARDS$110.2KDaniel Williams$13.7KFarhan Siddiq$10.0KPaul Deholl$8.8K
  1. 1

    Rakesh Chokshi

    $120,099.90 across 44 reported transactions

  2. 2

    Willie EDWARDS

    $110,181.80 across 21 reported transactions

  3. 3

    Daniel Williams

    $13,720.89 across 17 reported transactions

  4. 4

    Farhan Siddiq

    $10,000.00 across 2 reported transactions

  5. 5

    Paul Deholl

    $8,827.84 across 10 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

DeGen Medical, Inc.'s spend rank (#877 of 1,925, top 46% by spend) and concentration rank (#635 of 1,838, top 35% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.

01.83.75.57.32524.32550.225762601.82627.7Total payments ($M)Concentration (HHI, 0-10,000)
DeGen Medical, Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as DeGen Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about DeGen Medical, Inc..

Atrium Medical Corporation

HHI 2591

MIS Implants Technologies, Inc.

HHI 2592

Nutech Spine, Inc.

HHI 2564

Next Science LLC

HHI 2560

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with DeGen Medical, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

DeGen Medical, Inc. ranks #877 of 1,925 by all-tracks total payments, led by "Royalty or License".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download DeGen Medical, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.